# EDGAR Filing Document

**Accession Number:** 0001783723
**File Stem:** 0001493152-23-007404
**Filing Date:** 2023-3
**Character Count:** 8504
**Document Hash:** b4d66b8e82f18a23a9d986a745f075b7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-007404.hdr.sgml**: 20230313

**ACCESSION NUMBER**: 0001493152-23-007404

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20171026

**FILED AS OF DATE**: 20230313

**DATE AS OF CHANGE**: 20230313

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Ayanoglou John
- **CENTRAL INDEX KEY:** 0001783723

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40761
- **FILM NUMBER:** 23727408

**MAIL ADDRESS:**
- **STREET 1:** C/O 275 SHORELINE DRIVE, SUITE 150
- **CITY:** REDWOOD CITY
- **STATE:** CA
- **ZIP:** 94065
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BIOTRICITY INC.
- **CENTRAL INDEX KEY:** 0001630113
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 472548273
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0331

**BUSINESS ADDRESS:**
- **STREET 1:** 203 REDWOOD PARKWAY
- **STREET 2:** SUITE 600
- **CITY:** REDWOOD CITY
- **STATE:** CA
- **ZIP:** 94065
- **BUSINESS PHONE:** (650) 832-1626

**MAIL ADDRESS:**
- **STREET 1:** 203 REDWOOD PARKWAY
- **STREET 2:** SUITE 600
- **CITY:** REDWOOD CITY
- **STATE:** CA
- **ZIP:** 94065

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** METASOLUTIONS, INC.
- **DATE OF NAME CHANGE:** 20150107

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Ayanoglou John<br><sub>(Last) (First) (Middle)</sub><br>203 REDWOOD SHORES PARKWAY, SUITE 600<br><sub>(Street)</sub><br>REDWOOD CITY,, CA 94065<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2017-10-26 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Financial Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>BIOTRICITY INC. [ BTCY ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Warrants | $0.73 | 2017-10-26 |  | A |  | 50000 |  | <sup>(1)</sup> | 2030-12-31 | Common Stock | 50000 | $0 | 50000 | D |  |
| Warrants | $0.73 | 2018-03-31 |  | A |  | 50000 |  | <sup>(1)</sup> | 2030-12-31 | Common Stock | 50000 | $0 | 100000 | D |  |
| Warrants | $0.73 | 2018-06-30 |  | A |  | 50000 |  | <sup>(1)</sup> | 2030-12-31 | Common Stock | 50000 | $0 | 150000 | D |  |
| Warrants | $0.73 | 2018-09-30 |  | A |  | 50000 |  | <sup>(1)</sup> | 2030-12-31 | Common Stock | 50000 | $0 | 200000 | D |  |
| Warrants | $0.48 | 2018-12-31 |  | A |  | 50000 |  | <sup>(1)</sup> | 2028-12-30 | Common Stock | 50000 | $0 | 250000 | D |  |
| Warrants | $0.91 | 2019-03-31 |  | A |  | 50000 |  | <sup>(1)</sup> | 2029-03-30 | Common Stock | 50000 | $0 | 300000 | D |  |
| Warrants | $0.66 | 2019-06-30 |  | A |  | 50000 |  | <sup>(1)</sup> | 2029-06-29 | Common Stock | 50000 | $0 | 350000 | D |  |
| Warrants | $0.58 | 2019-09-30 |  | A |  | 50000 |  | <sup>(1)</sup> | 2029-09-29 | Common Stock | 50000 | $0 | 400000 | D |  |
| Warrants | $0.63 | 2019-12-31 |  | A |  | 50000 |  | <sup>(1)</sup> | 2029-12-30 | Common Stock | 50000 | $0 | 450000 | D |  |
| Warrants | $0.974 | 2020-03-31 |  | A |  | 50000 |  | <sup>(1)</sup> | 2030-03-31 | Common Stock | 50000 | $0 | 500000 | D |  |
| Warrants | $1.367 | 2020-06-30 |  | A |  | 50000 |  | <sup>(1)</sup> | 2030-06-30 | Common Stock | 50000 | $0 | 550000 | D |  |
| Warrants | $1.110 | 2020-09-30 |  | A |  | 50000 |  | <sup>(1)</sup> | 2030-09-30 | Common Stock | 50000 | $0 | 600000 | D |  |
| Warrants | $0.750 | 2020-01-24 |  | A |  | 50000 |  | <sup>(1)</sup> | 2030-01-23 | Common Stock | 50000 | $0 | 650000 | D |  |
| Warrants | $0.740 | 2020-12-31 |  | A |  | 50000 |  | <sup>(1)</sup> | 2030-12-31 | Common Stock | 50000 | $0 | 700000 | D |  |
| Warrants | $2.400 | 2021-03-31 |  | A |  | 50000 |  | <sup>(1)</sup> | 2031-03-31 | Common Stock | 50000 | $0 | 750000 | D |  |
| Warrants | $2.400 | 2021-06-30 |  | A |  | 50000 |  | <sup>(1)</sup> | 2031-06-30 | Common Stock | 50000 | $0 | 800000 | D |  |
| Warrants | $2.400 | 2021-09-30 |  | A |  | 50000 |  | <sup>(1)</sup> | 2031-09-30 | Common Stock | 50000 | $0 | 850000 | D |  |
| Warrants | $2.400 | 2021-12-31 |  | A |  | 50000 |  | <sup>(1)</sup> | 2031-12-31 | Common Stock | 50000 | $0 | 900000 | D |  |
| Warrants | $2.270 | 2022-03-31 |  | A |  | 37594 |  | <sup>(1)</sup> | 2032-03-31 | Common Stock | 37594 | $0 | 937594 | D |  |
| Warrants | $1.770 | 2022-06-30 |  | A |  | 53827 |  | <sup>(1)</sup> | 2032-06-30 | Common Stock | 53827 | $0 | 991421 | D |  |
| Warrants | $0.800 | 2022-09-30 |  | A |  | 118282 |  | <sup>(1)</sup> | 2032-09-30 | Common Stock | 118282 | $0 | 1109703 | D |  |
| Warrants | $0.448 | 2022-12-31 |  | A |  | 218785 |  | <sup>(1)</sup> | 2032-12-30 | Common Stock | 218785 | $0 | 1328488 | D |  |

---

### Footnotes:

(1) The Warrants were issued to the Reporting Person as a consideration for his services to the Issuer and are immediately exercisable.

**Signature:** /s/ John Ayanoglou  
**Date:** 2023-03-13

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**